panaxatriol has been researched along with Cardiovascular Stroke in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Gong, Y; He, Q; Huang, C; Li, X; Liu, W; Wei, S; Wu, H; Xu, Z; Yao, H; Zheng, C | 1 |
1 review(s) available for panaxatriol and Cardiovascular Stroke
| Article | Year |
|---|---|
Panaxatriol saponin ameliorates myocardial infarction-induced cardiac fibrosis by targeting Keap1/Nrf2 to regulate oxidative stress and inhibit cardiac-fibroblast activation and proliferation.
Topics: Animals; Cell Proliferation; Fibroblasts; Fibrosis; Ginsenosides; Hydrogen Peroxide; Kelch-Like ECH-Associated Protein 1; Molecular Docking Simulation; Myocardial Infarction; NF-E2-Related Factor 2; Oxidative Stress; Rats; Reactive Oxygen Species; Saponins; Signal Transduction; Superoxide Dismutase | 2022 |